Overview: Recent Advances in Organic Nitrates

References

• MURAD F: Drugs used for the treatment of angina: organic nitrates, calcium-chan-nel blockers and 0-adrenergic antagonists. In: The Pharmacological basis of therapeutics. (1990) Goodman Gilman A, Rail TW, Nies AS, Taylor P (Eds), 8th edition, New York, Perga-mon Press.
   Google Scholar
• SCIINEEWEISS A, WEISS M: Advances in nitrate therapy. (1990) Springer-Verlag, Berlin.
   Google Scholar
• Recent and complete review of nitrate therapy
   Google Scholar
• AHLNER J, ANDERSSON RGG, TORFGARD K, AXELSSON KL: Organic nitrate ester: clini-cal use and mechanisms of actions. Pharma-col. Rev. (1991) 43:351–423.
   PubMed Web of Science ®Google Scholar
• NATHANSON JA: Nitrovasodilators as a new class of ocular hypotensive agents. J. Phar-macol. Exp. Ther (1992) 260:956–965.
   PubMed Web of Science ®Google Scholar
• LOPEZ-BELMONTE J, WHITTLE BJR, MONCADA S: The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J. PharmacoL (1993) 108:73–78.
   PubMed Web of Science ®Google Scholar
• HISANO K, TOMOIKE H, INOLIE T, MOHRI M, NAKAMURA M: Isosorbide dinitrate ameliorates myocardial ischaemia after de-velopment of collateral function in a ca-nine model. J. Pharmacol. Exp. Ther. (1989) 248:1289–1296.
   PubMed Web of Science ®Google Scholar
• BRIEN JF, MCLAUGHLIN BE, BREEDON TH, BENNET BM, NAKATSU K, MARKS GS: Bio-transformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta. J. Pharmacol. Exp. Ther. (1986) 237:608–614.
   PubMed Web of Science ®Google Scholar
• IGNARRO LJ, LIPPTON H. EDWARDS JC, BARICOS WH, HYMAN AL, KADOWITZ PJ, GRUETTER CA: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitro-prusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active in-termediates. J. Pharmacol. Exp. Ther. (1981) 218:739–749
   PubMed Web of Science ®Google Scholar
• MONCADA S. PALMER RMJ, HIGGS EA: Ni-tric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. (1991) 43:109–142
   PubMed Web of Science ®Google Scholar
• NEEDLEMAN P, JOHNSON EM: Mechanism of tolerance development to organic nitrates. J. Pharmacol. Exp. Ther. (1973) 184:709–715.
   PubMed Web of Science ®Google Scholar
• TSUCHIDA S, MAKI T, SATO T: Purification and characterization of glutathione-S-trans-ferases with an activity toward nitroglycerin from human aorta and heat. J. Biol. Chem. (1990) 265:7150–7157.
   PubMed Web of Science ®Google Scholar
• SERVENT D, DELAFORGE M, DUCROCQ C, MANSUY D, LEFANT M: Nitric oxide for-mation during microsomal hepatic denitra-tion of glyceryl trinitrate: involvement of cy- -tochrome P450. Biochem. Biophys. Res. Corn-mun. (1989) 163:1210–1216.
   PubMed Web of Science ®Google Scholar
• SCHRODER H: Cytochrome P-450 mediates bioactivation of organic nitrates. J. Pharma-col. Exp. Ther. (1992) 262:298–302.
   PubMed Web of Science ®Google Scholar
• YEATES RA: Possible mechanisms of activa-tion of soluble guanylate cyclase by organic nitrates. Ar-zneim. Forsch. Drug Res. (1992) 42:1314–1317.
   PubMed Web of Science ®Google Scholar
• YEATES RA, SCHMID M, LEITOLD M: An-tagonism of glycerol trinitrate activity by an inhibition of glutathione-S-transferase. Biochem. Pharmacol. (1989) 38:1749–1753.
   PubMed Web of Science ®Google Scholar
• SAKANASHI M, MATSUZAKI T, ANIYA Y: Ni-troglycerin relaxes coronary artery of the pig with no change in glutathione content or glutathione-S-transferase activity. Br J. Pharmacol. (1991) 103:1905–1908.
   PubMed Web of Science ®Google Scholar
• SALVEMINI D, PISTELLI A, VANE J: Conver-sion of glyceryl trinitrate to nitric oxide in tolerant and non tolerant smooth muscle and endothelial cells. Br J. Pharmacol. (1993) 108:162–169.
   PubMed Web of Science ®Google Scholar
• CHUNG Si, FUNG HL: Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production. Biochem. Pharmacol. (1993) 45:157–163.
   PubMed Web of Science ®Google Scholar
• FLAHERTY JT: Nitrate tolerance: a review of the evidence. Drugs (1989) 37:523–550.
   PubMed Web of Science ®Google Scholar
• A thorough review of the evidence of the attenuation of nitrates effects.
   Google Scholar
• REICHEK N, ZIMRIN D, BOGIN K, DOUGLAS P et al.: Tolerance to antianginal effects of ni-troglycerin. Clin.Res. (1986) 34:338A
   Google Scholar
• SELLIER P. DARRAGON I, PAYEN B, AUDOUIN P, PORNIN M et al..: Therapeutic efficacy of' transdermal nitroglycerin (10mg) in angina pectoris evaluated by exercise testing. Xth World Congress of Cardiology (1986) Wash-ington Abstract 2840.
   Google Scholar
• REICHEK N, PRIEST C, ZIMRIN D, CHANDLER T, SurroN MSJ: Antianginal effects of nitro-glycerin patches. Am. J. Cardiol. (1984) 54:1–7.
   PubMed Web of Science ®Google Scholar
• PARKER JO, VANKOUGHNETT KA, FUNG HL: Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained ther-apy. Am. J. Cardiol. (1984) 54:8–13.
   PubMed Web of Science ®Google Scholar
• KHURMI NS, O'HARA MJ, BOWLES MJ, WHITT-INGTON JR, LAHIRI A et al.: Transmucosal and transdermal nitroglycerin delivery sys-tems for prevention of chronic stable angina pectoris. Br J. Clin. Pract. (1986) 40:187–191.
   Google Scholar
• SHARPE DN, COXON R: Nitroglycerinin a transdermal therapeutic system in chronic heart failure. Am. .1. Cardiol. (1984) 6:76–82.
   Google Scholar
• OLIVARI MT, CARLYLE PF, LEVINE TB, Col-IN JN: Haemodynamic and hormonal response to transdermal nitroglycerin in normal sub-jects and patients with congestive heart fail-ure. J. Am. Coll. Cardiol. (1983) 2:872–878.
   PubMed Web of Science ®Google Scholar
• FUNG HL, CHONG S, KOWALUK E: Mecha-nisms of nitrate action and vascular toler-ance. Eur. Heart J. (1989) 10(SupplA):2–6.
   Google Scholar
• An interesting review of the proposed mechanism for tol-erance development.
   Google Scholar
• FORSTER S, WODrTSCH I, SCHRODER H, SCHROR K: Reduced nitric oxide release causes ni-trates tolerance in the intact coronary cir-culation. J. Cardiovasc. Pharmacol. (1991) 17:867–872.
   PubMed Web of Science ®Google Scholar
• LIEBERMAN SM, Yu IM, WOLIN MS: Toler-ance to nitroglycerin in the isolated bovine intra-pulmonary artery is not associated with altered endothelium dependent relax-ation to acetylcholine, glutathione oxidation or modification of guanylate cyclase. Fed. Proc. (1985) 44, Abst.1234.
   Google Scholar
• GRUETTER CA, LEMKE SM: Dissociation of cysteine and glutathione levels from nitro-glycerin-induced relaxation. Eur Pharma-col. (1985) 111:85–95.
   PubMed Web of Science ®Google Scholar
• AXELSSON KL, ANDERSSON RGG: Tolerance towards nitroglycerin induced in vivo is cor-related to a reduced cGMP response and an alteration in cGMP turnover. Eur. J. Pharma-col. (1983) 88:71–79.
   PubMed Web of Science ®Google Scholar
• AXELSSON KL, KARLSSON JOG: Nitroglycerin tolerance in vitro: effect on cGMP turnover in vascular smooth muscle. Acta Pharmacol. Tox. (1984) 55:203–210.
   PubMedGoogle Scholar
• YATES RA, SCHMID M: Total prevention of the development of in vitro tolerance to or-ganic nitrates. Arzneim. Forsch. Drug Res. (1992) 42:297–302.
   PubMed Web of Science ®Google Scholar
• WALDMAN SA, RAPOPORT RM, GINSBURG R, MURAD F: Desensitization to nitroglycerin in vascular smooth muscle from rat and hu-man. Biochem. Pharmacol. (1986) 35:3525–3531.
   PubMed Web of Science ®Google Scholar
• HENRY PJ, HOROWITZ JD, Louis WJ: Nitro-glycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade. J. Pharmacol. Exp. Ther. (1989) 248:762–768.
   PubMed Web of Science ®Google Scholar
• PACKER M. LEE WH, KESSLER P, MEDINA N, YUSHAK M: Induction of nitrate tolerance in human heart failure by continuous in-travenous infusion of nitroglycerin and re-versal of tolerance by N-acetyl cysteine, a sulfhydryl donor. J. Am. Coll. Cardiol. (1986) 7:27A.
   Web of Science ®Google Scholar
• MAY DC, POPMA JJ, BLACK WH, SCHAEI+ER S. LEE HR et al.: In vivo induction and re-versal of nitroglycerin tolerance in human coronary arteries. New Engl. J. Med. (1987) 317:805–809.
   Google Scholar
• PARKER JO, FARRELL B, LANEY KA, ROSE BF: Nitrate tolerance: the lack of effect of N-acetyl cysteine. Circulation (1987) 76:572–576.
   PubMed Web of Science ®Google Scholar
• MUNZEL T, HOLTZ J, Mumai A, STEWART DJ, BASSENGE E: Nitrate tolerance in epicardial arteries or in the venous system is not re-versed by N-acetyl cysteine in vivo, but tol-erance independent interaction exist. Circu-lation (1989) 79:188–197.
   PubMed Web of Science ®Google Scholar
• WHITE A, HANDLER P, SMITH E, HILL R, LEHMAN IR: Principles of Biochemistry (1978) 6th Edition, Newfork McGraw Hill, pp687.
   Google Scholar
• NOACK E, KOJDA G: Nitric oxide liberating, soluble guanylate cyclase stimulating and vasorelaxing properties of the new nitrate compound SPM 3672. J. Cardiovasc. Phar-macol. (1993) 22:103–111.
   PubMed Web of Science ®Google Scholar
• KOJDA G, BECK JK, NOACK E: Nitrate action and tolerance in porcine vena cordis magna. Arch. Pharmacol. (1992) 346(Suppl 1):R34.
   Google Scholar
• STIPE AA, FINK GB: Prophylactic therapy of angina pectoris with organic nitrates: re-lationship of drug efficacy and clinical ex-perimental design. J. Clin. Pharmacol. (1973) 13:244–250.
   PubMedGoogle Scholar
• NIEDERER W, BETHGE 11D, BACHMANN K: Haemodynamic and ventricular dynamic in-vestigations of nitrate tolerance. In: Ni-trates and nitrates tolerance in angina pec-toris. (1983) Kaltenbach and Kuber (Eds), Steinkopff, Darmstadt.
   Google Scholar
• LEE G, MASON DT, DE MARIA AN: Effects of long term administration of isosorbide dini-trate on the antianginal response to nitro-glycerin. Am. J. Cardiol. (1978) 41:82–87.
   PubMedGoogle Scholar
• OHTSUKA M, SAKAI S, KUSUNOKI T, TANAKA T, TERAI T, ONO T, KIKUCHI H: Cardiovas-cular activity of FR-46171 a new pyridine alcohol derivative. Jpn. J. Pharmacol. (1985) 39(Suppl.):138P.
   Google Scholar
• TERADA T, SAKATA C, ISHIBASHI K, NAKAMURA T, ISHIMURA R, TSUCHIYA T, NOGUCHI H: Dis-position of 6-chloro-2-pyridylmethyl nitrate, a new anti-anginal compound in rats and dogs. Xenobiotica (1988) 18:291–300.
   PubMed Web of Science ®Google Scholar
• HAYASHI H, UENO H, SUZUKI F: Synthesis of stereoisomers of 1,4:3,6-dianhydrohexitol nitrate derivative, FR-14124. Bioorg. Med. Chem. Lett. (1992) 2:1187–1192.
   Web of Science ®Google Scholar
• IKEDA 1, KUBO K, SATO H, IMABEPPU S, KARASAWA A, HAYASHI H, SUZUKI F: Car-diovascular effects of KW-3196, a novel va-sodilator, in dogs. Jpn. J. Pharmacol. (1992) 58(Suppl 1):398.
   Google Scholar
• PRESSMAR F, NEIDLEIN R, STREIN K, BARTSCH W: Pharmacokinetics of the organic nitrates trans-2-amino-2-methyl-N-(4-nitroxycyclo-hexylmethyl)-propionamide in dogs, and of 4-(2-nitroxyethyl)-piperidine in dogs and in monkeys. Arzneim. Forsch. Drug Res. (1992) 42:1186–1191.
   PubMed Web of Science ®Google Scholar
• DIETMAN K, SPONER G, Voss E: Pharmaco-dynamics, pharmacokinetics and metabolism of isosorbide nitrate in awake dogs. Phar. Med. Welt (1981) 32:481–491.
   PubMedGoogle Scholar
• PRESSMAR F, NEIDLEIN R, STREIN K: Bio-transformation and pharmacokinetics of the nitrate trans-2-amino-2-methyl-N-(4-nitroxy cyclohexyl)-propionamide in dogs. Arzneim. Forsch. Drug Res. (1992) 42:1306–1311.
   PubMedGoogle Scholar
• WILLIAMSON JM, MEISTER A: Stimulation of hepatic glutathione formation by adminis-tration of L-2-oxothiazolidine-4-carboxilate, a 5-oxo-L-prolinase substrate. Proc. Natl. Acad. Sci. USA (1981) 78:936–939.
   PubMed Web of Science ®Google Scholar
• MA S, LONG JP: Central noradrenergic ac-tivity and the cardiovascular effects of ni-troglycerin and amyl nitrate. J. Cardiovasc. Pharmacol. (1992) 20:826–836.
   PubMed Web of Science ®Google Scholar
• HOLLENBERG M, GO M: Clinical studies with transdermal nitroglycerin. Am. Heart J. (1984) 108:223–231.
   PubMed Web of Science ®Google Scholar
• DELLE M, RICKSTEIN S. DELBRO D: Pre- and post-ganglionic sympathetic nerve activity during induced hypotension with adenosine or soditun nitroprusside in the anesthetized rat. Anesth. Analg. (1988) 67:307–312.
   PubMed Web of Science ®Google Scholar
• STREIN K, SPONER G, BARTSCH W, MULLER-BECKMANN B, DIETMANN: Electrocardio-graphic analysis of the effects of isosorbide-5-mononitrate on regional myocardial is-chaemia in conscious dogs. J. Pharmacol. Exp. Ther. (1984) 229:787–792.
   PubMed Web of Science ®Google Scholar
• VAN WOERKENS Li, VAN DER GIESSEN WJ, VERDOUW PD: Cardiovascular profile of 5 novel notroesters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction. Br. J. Pharmacol. (1991) 104:7–14.
   PubMed Web of Science ®Google Scholar
• LEVI S, BENEDLNI F, BERTOLINI G, CEREDA R, DoNA G, GROMO G, SALA A: Synthesis and cardiovascular activity of 3-nitroxyalky1-2,3-dihydro-4H-1,3-benzoxazin-4-ones, a novel class of nitrate esters. 12th Int. Symp. Med. Chem. (1992) Basel, Abst P152C.
   Google Scholar
• ROBERTSON DW, STEINBERG MI: Potassium channel modulators: scientific applications and therapeutic promise. J. Med. Chem. (1990) 33:1529–1541.
   PubMed Web of Science ®Google Scholar
• Interesting overview on the medicinal chemistry and phar-macology of potassium channel modulators.
   Google Scholar
• FURUKAWA K, trou T, KAJIWARA M, KITAMURAK, SUZUKI H, IT0 Y, KURIYAMA H: Vasodilat-ing actions of 2-nicotinamide ethyl nitrate on porcine and guinea-pig coronary arteries. J. Pharmacol. Exp. Then. (1981) 218:248–259.
   PubMedGoogle Scholar
• HOLZMANN S: Cyclic GMP as possible medi-ator of coronary arterial relaxation by nico-randil (SG-75). J. Cardiovasc. Pharmacol. (1983) 5:364–370.
   PubMed Web of Science ®Google Scholar
• HOLZMANN S, KUKOVETZ WR, BRAIDA C, POCH G: Pharmacological interaction exper-iments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil. Eur .1. Pharmacol. (1992) 215:1–5.
   PubMed Web of Science ®Google Scholar
• KuKovErz WR, HOLZMANN S, BRAIDA C, POCH G: Dual mechanism of the relaxing ef-fect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization. J. Cardiovasc. Pharmacol. (1991) 17:627–633.
   PubMed Web of Science ®Google Scholar
• TAIRA N: Nicorandil as a hybrid between ni-trates and potassium channel activators. Am. J. Cardiol. (1989) 63:18j–24j.
   Google Scholar
• KASHIWABARA T, ODAI H, KANETA S, TANAKA Y, FUKUSHIMA H, NISHIKORI K: Vasodilating and hypotensive properties of KRN-2391. Eur. J. Pharmacol. (1990) 183:1266.
   Web of Science ®Google Scholar
• SATAKE N, KIVOTO S. ZHOU Q, MATSUO M, SHIBATA S: Mode of relaxing action of FK-336, a new antianginal agent, in rabbit aorta. FASEB J.(1992) 6:Abst.360.
   Google Scholar
• KASHIWABARA T, NAKAJIMA S. IZAWA T, FUKUSHIMA H, NISHIKORI K: Characteris-tics of ICRN-2391, a novel vasodilator, com-pared with those of cromakalim, pinacidil and nifedipine in rat aorta. Eur J. Pharma-col. (1991) 196:1–7.
   PubMed Web of Science ®Google Scholar
• FUKATA Y, HARADA K, KASHIWABARA T, OGAWA N, FUKUSHIMA H, NISHIKORI K: Dif-ferent vasodilating mechanism of KRN-2391 on isolated canine large coronary and cra-nial mesenteric arteries. Jpn. J. Pharmacol. (1991) 55 (Supp1.1):253P.
   Google Scholar
• OGAWA N, FUKATA Y, KANETA S, JINNO Y, FUKUSHIMA H, NISHIKORI K: Comparison of KRN-2391 with Nicorandil and Nifedipine on canine coronary blood flow: antagonism by glibenclamide. J. Cardiovasc. Pharmacol. (1992) 20:11–17.
   PubMed Web of Science ®Google Scholar
• KANETA S, JLNNO Y, HARADA K, FUKUSHIMA H, OGAWA N: Tolerance to the increase in coronary blood flow induced by KRN-2391. Arch. Mt. Pharmacodyn. Ther. (1992) 318:21–35.
   PubMedGoogle Scholar
• AKABANE S, KATAYAMA S, ITABASHI A, INABA M, MARUNO Y, KASHIWABARA H, SANESHIGE S SENDA T, Ism J: Effects of nipradilol, a new nitroester-containing beta-blocker, on forearm blood flow. Current Ther. Res. (1992) 52:587–592.
   Web of Science ®Google Scholar
• UCHIDA Y, NAKAMURA M, SHIMIZU S. SHIRA-SAWA Y, FUJ1I M: Vasoactive and P-adrenore-ceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent. Arch. Int. Pharmaco-dyn. (1983) 262:132–149.
   Google Scholar
• KOYA D, KIKKAWA R, HANEDA M, Uzu T, SAWADA M, KAJIWARA N, SAKAMOTO K, SUGIMOTO T, SHIGETA Y: Nipradilol inhibits rat mesangial cell mitogenesis through the activation of soluble guanylate cyclase. Eur. .1. Pharmacol. (1993) 245:79–82.
   PubMed Web of Science ®Google Scholar
• RAPOPORT RM: Cyclic guanosine monophos-phate inhibition of contraction may be mediated through inhibition of phosphatidylinos-itolhydrolysis in rat aorta. Circ. Res. (1986) 58:407–410.
   PubMed Web of Science ®Google Scholar
• TWORT CHC, VAN BREEMEN C: Cyclic guano-sine monophosphate enhanced sequestration of Ca2+ by sarcoplasmic reticulum in vascu-lar smooth muscle. Circ. Res. (1988) 62:961–964.
   PubMed Web of Science ®Google Scholar
• MIYAMOTO Y, NOGUCHI K, NAKASONE J, SAKANASHI M: Pharmacological properties of 5-[(6,7,8-trimethoxy-4-quinazolinyflamino]-1-pentanyl nitrate maleate in cardiovascu-lar system. Arzneim. Forsch. Drug Res. (1991) 41:1216–1221.
   PubMedGoogle Scholar
• HIDAKA H. TANAKA T, ITOH H: Selective in-hibitors of three forms of cyclic nucleotide phosphodiesterase. Trends Pharmacol. Sci. (1984) 5:237–239.
   Web of Science ®Google Scholar
• KAWASHIMA Y, TOMOYUKI I, AKIYO H, MASA-TOSHI H, KEITA M, KAWARASAKI K, RYUZABURO Y, SHIGERU 0, KATSUO K: Synthesis and pharmacological evaluation of (nitrooxy)alkyl Apovincaminates. J. Med. Chem. (1993) 36: 815–819.
   PubMed Web of Science ®Google Scholar
• OGAWA T, NAKAZATO A, TSUCHIDA K, HATAYAMA K: Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives con-taining nitrooxyalkylester moieties at the 3-and 5- positions. Chem. Pharm. Bull. (1993) 41:1049–1054.
   PubMed Web of Science ®Google Scholar
• KAWASHIMA Y, OGAWA T, KATO M, NAKAZATO A, TSUCHIDA K, HATAYAMA K, HIRONO S, MORIGUCHI I: Structure-activity study of antihypertensive 1,4-dihydropyridine deriva-tives having nitrooxyalkylester moieties at the 3- and 5- positions. Chem. Pharm. Bull. (1993) 41:1060–1065.
   PubMed Web of Science ®Google Scholar
• STERK GJ, VANDER WERF JF, VEERMAN MEJ, TIMMERMANN H, BRON J: New hybrids with Ca-antagonistic and nitrovasodilator activ-ity. 9th Noordwijkerhout-Camerino Symposium - Trends in drug research (1993) (The Nether-lands).
   Google Scholar
• HARRISON DG, BATES JN: The nitrovasodila-tors. New ideas about old drugs. Circulation (1993) 87:1461–1467.
   PubMed Web of Science ®Google Scholar
• HAYASHI H, I10EDA J, KURODA T, KUBO K, SANO T, Suzuxi F: 1,4:3,6-dianhydrohexitol nitrate derivatives. I. Synthesis and antiang-inal activity of alkylpiperazine derivatives. Chem. Pharm Bull. (1993) 41:1091–1099.
   Google Scholar
• HAYASHI H, IICEDA J, Kuso K, MORIYAMA T, KARASAWA A, Suzum F: 1,4:3,6-dianhydro-hexitol nitrate derivatives. H. Synthesis and antianginal activity of arylcarbonylpiperazine derivatives. Chem. Pharm Bull. (1993) 41:1100–1110.
   Google Scholar